Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury
Author(s) -
Sophia M. Sears,
Tess V. Dupre,
Parag P. Shah,
Deanna Davis,
Mark A. Doll,
Cierra N. Sharp,
Alexis A. Vega,
Judit Megyesi,
Levi J. Beverly,
Ashley J. Snider,
Lina M. Obeid,
Yusuf A. Hannun,
Leah J. Siskind
Publication year - 2022
Publication title -
journal of lipid research
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.992
H-Index - 192
eISSN - 1539-7262
pISSN - 0022-2275
DOI - 10.1016/j.jlr.2022.100179
Subject(s) - acute kidney injury , cisplatin , nephrotoxicity , autophagy , ceramide , programmed cell death , sphingolipid , sphingosine , apoptosis , cancer research , knockout mouse , pharmacology , downregulation and upregulation , kidney , chemistry , medicine , endocrinology , chemotherapy , biochemistry , receptor , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom